Comparison of instruments for measuring the quality of life impairment syndrome in severe mental disorders Q-LES-Q versus QLS and LQOLP

Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment

Volumn , Issue , 2007, Pages 133-142

  Ritsner, Michael S ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Comparison; Psychiatric patients; Quality of life scales; Reliability; Validity

Indexed keywords

EID: 84866976300     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-5779-3_7     Document Type: Chapter

References (47)

1. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993; 29: 321-326.
2. Heinrichs DW, Hanlon TE, Carpenter WT Jr. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984; 10:388-398.
3. Oliver J, Huxley P, Bridges K, Mohammed H. Quality of Life and Mental Health Service. London & New York: Routledge, 1996.
4. Van Nieuwenhuizen C, Schene AH, Boevink WA, Wolf JRLM. Measuring the quality of life of clients with severe mental illness: a review of instruments. Psychiatr Rehabil J 1997; 20:33-41.
5. Awad AG, Voruganti LN, Heslegrave RJ. Measuring quality of life in patients with schizophrenia. Pharmacoeconomics. 1997; 11:32-47.
6. Bishop SL, Walling DP, Dott SG, Folkes CC, Bucy J. Refining quality of life: validating a multidimensional factor measure in the severe mentally ill. Qual Life Res 1999; 8:151-160.
7. Hawthorne G, Richardson J. Measuring the value of program outcomes: a review of multiattribute utility measures. Expert Rev. Pharmacoeconomics Outcomes Res. 2001; 1: 215-228.
8. Trauer T, Duckmanton RA, Chiu E. A study of the quality of life of the severely mentally ill. Int J Soc Psychiatry 1998; 44:79-91.
9. Lobana A, Mattoo SK, Basu D, et al. Quality of life in schizophrenia in India: comparison of three approaches. Acta Psychiatr Scand 2001; 104:51-55.
10. Fitzgerald PB, Williams CL, Corteling N, et al. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand 2001; 103:387-392.
11. Ruggeri M, Bisoffi G, Fontecedro L, et al. Subjective and objective dimensions of quality of life in psychiatric patients: a factor analytical approach: The South Verona Outcome Project 4. Br J Psychiatry 2001; 178:268-275.
12. Lehman AF, Postrado LT, Rachuba LT. Convergent validation of quality of life assessments for persons with severe mental illnesses. Qual. Life Res. 1993: 2: 327-333.
13. Oliver JP, Huxley PJ, Priebe S, Kaiser W. Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Soc Psychiatry Psychiatr Epidemiol 1997; 32:76-83.
14. Ritsner M, Modai I, Endicott J, et al. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000; 61:880-889.
15. Ritsner M, Ponizovsky A, Endicott J, et al. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study. Eur Neuropsychopharmacol 2002; 12:31-38.
16. Rossi A, Rucci P, Mauri M, Maina G, Pieraccini F, Pallanti S, Endicott J; (For the EQUIP group). Validity and reliability of the Italian version of the Quality of Life, Enjoyment and Satisfaction Questionnaire. Qual Life Res. 2005; 14(10):2323-8.
17. Ozer S, Ulusahin A, Batur S, et al. Outcome measures of interepisode bipolar patients in a Turkish sample.Soc Psychiatry Psychiatr Epidemiol. 2002; 37:31-37.
18. Seidman SN, Rabkin JG. Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord. 1998; 48: 157-161.
19. Russell JM, Koran LM, Rush J, et al. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depress Anxiety. 2001;13:18-27.
20. Michalak EE, Tam EM, Manjunath CV, et al. Quality of life in patients with seasonal affective disorder: summer vs winter scores. Can J Psychiatry. 2005; 50:292-295.
21. Goracci A, Martinucci M, Scalcione U, et al. Quality of life and subthreshold affective symptoms. Qual Life Res. 2005; 14:905-909.
22. Pearlstein TB, Halbreich U, Batzar ED, et al. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry 2000; 61:101-109.
23. Ritsner M, Kurs R, Gibel A, et al. Predictors of quality of life in major psychoses: a naturalistic follow-up study. J Clin Psychiatry 2003; 64:308-315.
24. Rapaport MH, Endicott J, Clary CM. Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment. J Clin Psychiatry. 2002; 63: 59-65.
25. Ritsner M, Kurs R, Gibel A, et al. Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Qual Life Res. 2005; 14:1693-1703.
26. Katschnig, H. How useful is the concept of quality of life in psychiatry? Curr Opin Psychiatry 1997; 10: 337-345.
27. Ritsner M, Kurs R. Impact of antipsychotic agents and their side effects on the quality of life in schizophrenia. Expert Review and Pharmacoeconomic Outcomes Research 2002; 2: 89-98.
28. Ritsner M, Kurs R. Quality of life outcomes in mental illness: schizophrenia, mood and anxiety disorders. Expert Review and Pharmacoeconomic Outcomes Research 2003; 3:189-199.
29. Bilker, W.B., Brensinger, C., Kurtz, M.M., et al. Development of an abbreviated schizophrenia quality of life scale using a new method. Neuropsychopharmacology 2003; 28: 773-777.
30. Ritsner M, Kurs R, Ratner Y, Gibel A. Condensed version of the Quality of Life Scale for schizophrenia for use in outcome studies. Psychiatry Res. 2005; 135:65-75.
31. Hamilton SH, Revicki DA, Edgell ET, et al. Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial. Pharma-coeconomics. 1999;15: 469-480.
32. Kaneda Y, Ohmori T. Effects of quetiapine on gonadal axis hormones in male patients with schizophrenia: a preliminary, open study. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27:875-878.
33. Kaneda Y, Imakura A, Fujii A, Ohmori T. Schizophrenia Quality of Life Scale: validation of the Japanese version. Psychiatry Res. 2002;113:107-113.
34. Cramer JA, Rosenheck R, Xu W, et al. Quality of Life in Schizophrenia: A Comparison of Instruments. Schizophr Bull 2000; 26: 659-666.
35. Ritsner, M., Perelroyzen, G., Kurs, R., et al. Quality of life outcomes in schizophrenia patients treated with atypical and typical antipsychotic agents: A naturalistic comparative study. International Clinical Psychopharmacology 2004; 24:582-591.
36. Ritsner M, Perelroyzen G, Ilan H, Gibel A. Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice: a naturalistic comparative study. J Clin Psychophar-macol. 2004; 24:245-54.
37. Ritsner MS, Gibel, A. The effectiveness and predictors of response to antipsychotic agents to treat impaired quality of life in schizophrenia: a 12-month naturalistic follow-up study with implications for confounding factors, antidepressants, anxiolytics, and mood stabilizers. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006; 30:1442-1452.
38. Voruganti L, Cortese L, Oyewumi L, et al. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophr. Res 2000; 43:135-145.
39. Gourevitch R, Abbadi S, Guelfi JD. Quality of life in schizophrenics with and without the deficit syndrome. Eur Psychiatry. 2004; 19:172-174.
40. Lehman AF. (1995) Measuring quality of life in a reformed health system. Health Affairs 1995; 14: 90-101.
41. Ritsner M, Modai I, Kurs R, et al. Subjective Quality of Life Measurements in Severe Mental Health Patients: Measuring Quality of Life of Psychiatric Patients: Comparison Two Questionnaires. Quality Life Research 2002; 11: 553-561.
42. Awad AG, Voruganti LN. Impact of atypical antipsychotics on quality of life in patients with schizophrenia. CNS Drugs. 2004; 18:877-893.
43. Lambert M, Naber D. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs. 2004 (Suppl 2): 5-17; discussion 41-43.
44. Voruganti L, Heslegrave R, Awad AG, Seeman MV. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 1998; 28:165-172.
45. McKenna, S.P. Measuring quality of life in schizophrenia. Eur. Psychiatry 1997 (Suppl. 3), 267s-274s.
46. Wilkinson, G., Hesdon, B., Wilde, D., et al. Self-report quality of life measure for people with schizophrenia: the SQLS. Br. J. Psychiatry 2000; 177: 42-46.
47. Bernhard J, Lowy A, Mathys N, et al. Health related quality of life: a changing construct? Qual Life Res. 2004; 13:1187-1197.